Abstract:Abstract Introduction Sleep apnea and insomnia often co-occur in older adults, complicating treatment and worsening outcomes. More research is needed to characterize sleep apnea patients with and without co-morbid insomnia. We characterized differences in demographic and clinical characteristics between individuals with co-morbid insomnia and sleep apnea (COMISA) and those with sleep apnea alone in a national sample of U.S. middle-aged and older adults. Methods Data came from the 2018 interview of the Health and Retirement Study, a nationally representative cohort of approximately 20,000 U.S. older adults. Participants were asked if “a doctor had ever told them they have a sleep disorder,” and if so, which disorder, including sleep apnea. Participants reported frequency of insomnia symptoms (difficulty falling asleep, waking during the night, waking too early, and feeling rested in the morning), and were categorized as having each symptom if they reported experiencing the symptom “most of the time” for the first three symptoms and “rarely or never” for the latter. Employing bi-variate logistic regression, we compared demographic and clinical characteristics of participants with sleep apnea who reported ≥1 insomnia symptom (COMISA) to those reporting 0 symptoms (sleep apnea alone). Results Among N=1,816 respondents reporting sleep apnea, 47.2% also had insomnia symptoms (COMISA). Compared to those with sleep apnea alone, participants with COMISA were younger (65.3±9.61 years vs. 66.4±9.25, p=0.015), and more likely to be female (51.5% vs. 40.3%, p< 0.001), but did not differ by race and ethnicity. They also were more likely to report several health conditions, including a markedly higher prevalence of mental health problems (43.1% vs. 24.8%, p< 0.001), dementia/cognitive impairment (4.9% vs. 2.7%, p< 0.001), and also have greater depressive symptomatology as measured by CES-D (2.8±2.44 vs. 1.1±1.67, p< 0.001). Conclusion Notable differences were identified between participants with COMISA and those with OSA alone. Of note, COMISA patients were more likely to have several health conditions, especially mental health, which suggests COMISA patients may benefit from psychosocial interventions aimed at improving treatment adherence and preventing poor health outcomes. Support (if any) This study was supported by the National Institute on Aging (R01AG079391, K01AG061239, P30AG028740) and the Sleep Research Society Foundation (23-FRA-001).

What problem does this paper attempt to address?

The paper mainly explores three related but independent research topics: ### Part 1: The Impact of Insomnia, Obstructive Sleep Apnea (OSA), and Their Comorbidity (COMISA) on Functional Outcomes in U.S. Veterans - **Research Background**: In U.S. veterans, the additional burden that insomnia, obstructive sleep apnea (OSA), and their comorbidity (COMISA) may have on patient-reported outcomes (PROs) is unclear. Additionally, the differences in chronotype among these sleep disorder groups and their independent contributions to PROs have not been explored. - **Research Methods**: Veterans at risk for OSA were assessed at the Miami VA Sleep Center over a year. Data were collected through home polysomnography (PSG) and questionnaires, including demographic information, the Insomnia Severity Index (ISI), and the Patient-Reported Outcomes Measurement Information System (PROMIS-29). OSA was diagnosed with an AHI ≥ 5 on PSG, and insomnia was diagnosed with an ISI ≥ 15. COMISA was diagnosed if both criteria were met. Self-reported chronotype was categorized as morning type, somewhat morning type, somewhat evening type, or evening type. - **Research Results**: The study included 387 veterans (85% male, average age 52), with 16% having only OSA, 18% having only insomnia, and 67% meeting the criteria for COMISA. Compared to the OSA group, participants in the insomnia group were more likely to be female, have a lower BMI, and be younger. There were no significant differences in the distribution of chronotype among the different sleep disorder groups. Regression analyses showed that participants in the insomnia and COMISA groups had worse outcomes in anxiety, depression, fatigue, sleep disturbance, social disruption, physical function, and pain interference compared to those with only OSA. However, chronotype was not related to these PROs in analyses grouped by sleep disorder. - **Conclusion**: Veterans with COMISA and those with only insomnia are more functionally impaired than those with only OSA. However, the distribution of chronotype is similar among different sleep disorder groups, and chronotype itself is not related to PROs. Larger studies and objective chronotype measurement methods are needed to replicate these findings. ### Part 2: Characteristics of Middle-Aged and Older Adults with Comorbid Insomnia and Sleep Apnea Compared to Those with Only Sleep Apnea - **Research Background**: Sleep apnea and insomnia often coexist in older populations, complicating treatment and worsening prognosis. More research is needed to describe the characteristics of sleep apnea patients with and without comorbid insomnia. - **Research Methods**: Data from the 2018 Health and Retirement Study, a nationally representative cohort study of approximately 20,000 middle-aged and older U.S. adults, were used. The study compared the characteristics of sleep apnea patients with and without insomnia symptoms. - **Research Results**: Among the 1,816 respondents reporting sleep apnea, 47.2% also had insomnia symptoms (COMISA). Compared to participants with only OSA, those in the COMISA group were younger, more likely to be female, and reported more health issues, particularly mental health problems. - **Conclusion**: Participants with COMISA differ significantly from those with only OSA, particularly in their higher likelihood of having multiple health issues, especially mental health problems. This suggests that psychosocial interventions aimed at improving treatment adherence and preventing adverse health outcomes may benefit COMISA patients. ### Part 3: The Impact of Buprenorphine and Naltrexone on Sleep-Related Breathing Events - **Research Background**: Opioids are associated with an increased risk of sleep-related breathing events, particularly central sleep apnea. This part of the study focuses on the effects of the partial agonist buprenorphine and the full antagonist naltrexone on sleep-related breathing events. - **Research Objective**: To investigate the impact of buprenorphine and naltrexone on breathing events during sleep. The subsequent sections are not fully provided, but from the introduction, it appears that this part aims to compare the two.

0493 Characteristics of Middle-Aged and Older Adults with Comorbid Insomnia and Sleep Apnea vs. Sleep Apnea Alone